EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran



RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran



International Journal of Laboratory Hematology 29(5): 321-326



beta-thalassemia is considered a severe, progressive anemia, which needs regular transfusions for life expectancy. One of the most important complications of regular blood transfusions may be alloimmunization, which increases the need for transfusion. This study was performed to investigate the production of red cell alloantibodies in beta-thalassemia patients in Shiraz, southern Iran. Blood sampling was performed among 711 beta-thalassemia patients in Dastgheib hospital in 2002-2004. Direct and indirect coombs tests were performed to check the auto and alloantibodies and a panel test was conducted to detect the type of alloantibodies. Auto and alloantibodies were observed among 1.7% and 5.3% of patients, respectively. The most common alloantibodies were Anti-kell (50%) > Anti-Rh (D) (15.8%) > Anti-Rh (E) (10.5%). All the patients who had developed alloantibody were in the age group of 6 years or more. So for decreasing the rate of alloantibody synthesis, we should crossmatched the packed cells for minor blood groups especially for kell and Rh(E) in addition to major blood groups from the start of transfusion.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333587

Download citation: RISBibTeXText

PMID: 17824911

DOI: 10.1111/j.1365-2257.2006.00856.x



Related references

Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt. Transfusion and Apheresis Science 53(1): 52-57, 2016

Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. Blood 97(12): 3999-4000, 2001

Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion 52(1): 43-47, 2012

Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. Transfusion 45(5): 761-765, 2005

Alloimmunization among transfusion-dependent thalassemia patients. Asian Journal of Transfusion Science 3(2): 95-98, 2009

Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfusion Medicine 16(3): 200-203, 2006

RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 43(11): 1604-1610, 2003

Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Transfusion 56(9): 2303-2307, 2017

Alloimmunization and autoimmunization in predominantly Asian transfusion dependent thalassemia patients. Blood 94(10 SUPPL 1 PART 1): 422a-423a, Nov 15, 1999

Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatric Hematology and Oncology 28(6): 479-485, 2011

Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients. Asian Journal of Transfusion Science 8(2): 84-88, 2014

Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 96(10): 3369-3373, 2000

Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients. Indian Journal of Clinical Biochemistry 30(2): 198-203, 2015

Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients. Clinical Laboratory 59(7-8): 861-868, 2013

Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review. Transfusion: -, 2018